{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:22:51Z","timestamp":1771273371947,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201c333 Project\u201d of Jiangsu Province,China","award":["[2022]3-25-049"],"award-info":[{"award-number":["[2022]3-25-049"]}]},{"name":"Key program of Administration of Traditional Chinese Medicine of Jiangsu Province, China","award":["ZX202102"],"award-info":[{"award-number":["ZX202102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18867-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:38:29Z","timestamp":1758886709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of regulated cell death related genes in polycystic ovary syndrome using machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Ronghuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongkui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"18867_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman, N. F. et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2. Endocr. Pract. 21, 1415\u20131426 (2015).","journal-title":"Endocr. Pract."},{"key":"18867_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman, N. F. et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2013part 1. Endocr. Pract. 21, 1291\u20131300 (2015).","journal-title":"Endocr. Pract."},{"key":"18867_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva, D. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106, 6\u201315 (2016).","journal-title":"Fertil. Steril."},{"key":"18867_CR4","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijerph15112589","volume":"15","author":"WM Wolf","year":"2018","unstructured":"Wolf, W. M., Wattick, R. A., Kinkade, O. N. & Olfert, M. D. Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. Int. J. Environ. Res. Public. Health. 15, 2589 (2018).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"18867_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz, R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J. Clin. Endocrinol. Metab. 91, 781\u2013785 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18867_CR6","doi-asserted-by":"publisher","first-page":"12507","DOI":"10.3390\/ijms222212507","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka, E. et al. Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int. J. Mol. Sci. 22, 12507 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"18867_CR7","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci. 22, 3789 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"18867_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L. & Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37, 467\u2013520 (2016).","journal-title":"Endocr. Rev."},{"key":"18867_CR9","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini, D., Boscaro, M., Bordin, L. & Sabbadin, C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int. J. Mol. Sci. 23, 4110 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"18867_CR10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"18867_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","volume":"12","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis, E. & Papavassiliou, A. G. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol. Med. 12, 324\u2013332 (2006).","journal-title":"Trends Mol. Med."},{"key":"18867_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis, E. & Dunaif, A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981\u20131030 (2012).","journal-title":"Endocr. Rev."},{"key":"18867_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz, B. O., Knochenhauer, E. S. & Azziz, R. Impact of obesity on the risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93, 162\u2013168 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18867_CR14","first-page":"267","volume":"50","author":"LG Nardo","year":"2008","unstructured":"Nardo, L. G., Patchava, S. & Laing, I. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications. Panminerva Med. 50, 267\u2013278 (2008).","journal-title":"Panminerva Med."},{"key":"18867_CR15","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1210\/jc.2003-031545","volume":"89","author":"LA Cal\u00f2","year":"2004","unstructured":"Cal\u00f2, L. A. et al. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J. Clin. Endocrinol. Metab. 89, 1973\u20131976 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18867_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"Tilg, H. & Moschen, A. R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14, 222\u2013231 (2008).","journal-title":"Mol. Med."},{"key":"18867_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould, A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J. Endocrinol. 192, 585\u2013594 (2007).","journal-title":"J. Endocrinol."},{"key":"18867_CR18","doi-asserted-by":"publisher","first-page":"e4274","DOI":"10.1371\/journal.pone.0004274","volume":"4","author":"MC Allemand","year":"2009","unstructured":"Allemand, M. C. et al. Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes\u2013a potential model for PCOS-related insulin resistance. PLoS One. 4, e4274 (2009).","journal-title":"PLoS One"},{"key":"18867_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell. Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell. Death Differ."},{"key":"18867_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-022-01260-0","volume":"15","author":"M Liao","year":"2022","unstructured":"Liao, M. et al. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J. Hematol. Oncol. 15, 44 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"18867_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal. Transduct. Target. Ther. 7, 286 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"18867_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and Cuproptosis research. J. Hematol. Oncol. 15, 174 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"18867_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-020-00677-x","volume":"18","author":"Y Gong","year":"2020","unstructured":"Gong, Y. et al. Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod. Biol. Endocrinol. 18, 121 (2020).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"18867_CR24","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","volume":"17","author":"S Kumariya","year":"2021","unstructured":"Kumariya, S., Ubba, V., Jha, R. K. & Gayen, J. R. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy 17, 2706\u20132733 (2021).","journal-title":"Autophagy"},{"key":"18867_CR25","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3892\/mmr.2020.11338","volume":"22","author":"Y Wu","year":"2020","unstructured":"Wu, Y., Li, W., Hu, Y., Liu, Y. & Sun, X. Suppression of Sirtuin 1 alleviates airway inflammation through mTOR\u2013mediated autophagy. Mol. Med. Rep. 22, 2219\u20132226 (2020).","journal-title":"Mol. Med. Rep."},{"key":"18867_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","volume":"55","author":"E Lee","year":"2023","unstructured":"Lee, E., Song, C. H., Bae, S. J., Ha, K. T. & Karki, R. Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis. Exp. Mol. Med. 55, 1632\u20131643 (2023).","journal-title":"Exp. Mol. Med."},{"key":"18867_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41698-024-00570-5","volume":"8","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response. NPJ Precis Oncol. 8, 77 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"18867_CR28","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Zeh, H. J., Kang, R., Kroemer, G. & Tang, D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat. Rev. Gastro Hepat. 18, 804\u2013823 (2021).","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"18867_CR29","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41419-021-04397-x","volume":"12","author":"VS Gadepalli","year":"2021","unstructured":"Gadepalli, V. S., Kim, H., Liu, Y., Han, T. & Cheng, L. XDeathDB: a visualization platform for cell death molecular interactions. Cell. Death Dis. 12, 1156 (2021).","journal-title":"Cell. Death Dis."},{"key":"18867_CR30","doi-asserted-by":"crossref","unstructured":"Garg, A. D., De Ruysscher, D. & Agostinis, P. Immunological metagene signatures derived from Immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis. OncoImmunology 5, e1069938 (2016).","DOI":"10.1080\/2162402X.2015.1069938"},{"key":"18867_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze, C. et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat. Immunol. 19, 130\u2013140 (2018).","journal-title":"Nat. Immunol."},{"key":"18867_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates Disulfidptosis. Nat. Cell. Biol. 25, 404\u2013414 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"18867_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41556-023-01100-4","volume":"25","author":"LM Machesky","year":"2023","unstructured":"Machesky, L. M. Deadly actin collapse by Disulfidptosis. Nat. Cell. Biol. 25, 375\u2013376 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"18867_CR34","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"18867_CR35","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. 107, 106936 (2022).","journal-title":"Int. J. Surg."},{"key":"18867_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12859-019-3247-x","volume":"20","author":"ZB Abrams","year":"2019","unstructured":"Abrams, Z. B., Johnson, T. S., Huang, K., Payne, P. R. O. & Coombes, K. A protocol to evaluate RNA sequencing normalization methods. BMC Bioinf. 20, 679 (2019).","journal-title":"BMC Bioinf."},{"key":"18867_CR37","doi-asserted-by":"publisher","first-page":"15e","DOI":"10.1093\/nar\/30.4.e15","volume":"30","author":"YH Yang","year":"2002","unstructured":"Yang, Y. H. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, 15e\u2013115 (2002).","journal-title":"Nucleic Acids Res."},{"key":"18867_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/1471-2105-12-467","volume":"12","author":"J Rudy","year":"2011","unstructured":"Rudy, J. & Valafar, F. Empirical comparison of cross-platform normalization methods for gene expression data. BMC Bioinf. 12, 467 (2011).","journal-title":"BMC Bioinf."},{"key":"18867_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"18867_CR40","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"18867_CR41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"18867_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"18867_CR43","doi-asserted-by":"publisher","first-page":"967151","DOI":"10.3389\/fimmu.2022.967151","volume":"13","author":"W Tan","year":"2022","unstructured":"Tan, W. et al. MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome. Front. Immunol. 13, 967151 (2022).","journal-title":"Front. Immunol."},{"key":"18867_CR44","doi-asserted-by":"publisher","first-page":"111141","DOI":"10.1016\/j.intimp.2023.111141","volume":"125","author":"Y Xiang","year":"2023","unstructured":"Xiang, Y. et al. Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia. Int. Immunopharmacol. 125, 111141 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"18867_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis, E., Papavassiliou, A. G., Kandarakis, S. A. & Chrousos, G. P. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol. Metab. 18, 280\u2013285 (2007).","journal-title":"Trends Endocrinol. Metab."},{"key":"18867_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","volume":"94","author":"M Wang","year":"2019","unstructured":"Wang, M. et al. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome. Metabolism 94, 47\u201358 (2019).","journal-title":"Metabolism"},{"key":"18867_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","volume":"185","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients. J. Steroid Biochem. Mol. Biol. 185, 142\u2013149 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"18867_CR48","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3390\/ijms21144853","volume":"21","author":"A Rajska","year":"2020","unstructured":"Rajska, A., Buszewska-Forajta, M., Racho\u0144, D. & Markuszewski, M. J. Metabolomic insight into polycystic ovary Syndrome-An overview. Int. J. Mol. Sci. 21, 4853 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"18867_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1586\/eem.12.42","volume":"7","author":"R Pasquali","year":"2012","unstructured":"Pasquali, R. & Gambineri, A. Cortisol and the polycystic ovary syndrome. Expert Rev. Endocrinol. Metab. 7, 555\u2013566 (2012).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"18867_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","volume":"29","author":"L Ib\u00e1\u00f1ez","year":"2023","unstructured":"Ib\u00e1\u00f1ez, L. & de Zegher, F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol. Med. 29, 354\u2013363 (2023).","journal-title":"Trends Mol. Med."},{"key":"18867_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell. Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"18867_CR52","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.12659\/MSM.909098","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang, Y., He, J. & Yang, J. Eicosapentaenoic acid improves polycystic ovary syndrome in rats via sterol regulatory Element-Binding protein 1 (SREBP-1)\/Toll-Like receptor 4 (TLR4) pathway. Med. Sci. Monit. 24, 2091\u20132097 (2018).","journal-title":"Med. Sci. Monit."},{"key":"18867_CR53","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2337\/diabetes.53.8.2153","volume":"53","author":"D Eberl\u00e9","year":"2004","unstructured":"Eberl\u00e9, D. et al. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 53, 2153\u20132157 (2004).","journal-title":"Diabetes"},{"key":"18867_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.repbio.2020.05.004","volume":"20","author":"D Prabhu","year":"2020","unstructured":"Prabhu, D. Valsala gopalakrishnan, A. \u03b3-Linolenic acid ameliorates DHEA induced pro-inflammatory response in polycystic ovary syndrome via PPAR-\u03b3 signaling in rats. Reprod. Biol. 20, 348\u2013356 (2020).","journal-title":"Reprod. Biol."},{"key":"18867_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/aogs.13106","volume":"96","author":"MN Shafiee","year":"2017","unstructured":"Shafiee, M. N. et al. Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Acta Obstet. Gynecol. Scand. 96, 556\u2013562 (2017).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"18867_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejogrb.2015.03.002","volume":"188","author":"L Li","year":"2015","unstructured":"Li, L. et al. 54G\/C polymorphism of SREBF-1 gene is associated with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 188, 95\u201399 (2015).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"18867_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fendo.2020.00284","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Dietary \u03b1-Linolenic Acid-Rich flaxseed oil exerts beneficial effects on polycystic ovary syndrome through sex steroid Hormones-Microbiota-Inflammation axis in rats. Front. Endocrinol. (Lausanne). 11, 284 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"18867_CR58","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1038\/s41598-024-56970-x","volume":"14","author":"W Zhang","year":"2024","unstructured":"Zhang, W. & Wu, F. Linoleic acid induces human ovarian granulosa cell inflammation and apoptosis through the ER-FOXO1-ROS-NF\u03baB pathway. Sci. Rep. 14, 6392 (2024).","journal-title":"Sci. Rep."},{"key":"18867_CR59","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.3390\/ijms232314663","volume":"23","author":"D Szukiewicz","year":"2022","unstructured":"Szukiewicz, D., Trojanowski, S., Kociszewska, A. & Szewczyk, G. Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)-Searching for epigenetic factors. Int. J. Mol. Sci. 23, 14663 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"18867_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10555-020-09951-1","volume":"40","author":"K Rawat","year":"2021","unstructured":"Rawat, K., Syeda, S. & Shrivastava, A. Neutrophil-derived granule cargoes: paving the way for tumor growth and progression. Cancer Metastasis Rev. 40, 221\u2013244 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"18867_CR61","doi-asserted-by":"publisher","first-page":"1169232","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J., Yin, T. & Liu, S. Dysregulation of immune response in PCOS organ system. Front. Immunol. 14, 1169232 (2023).","journal-title":"Front. Immunol."},{"key":"18867_CR62","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas, M. & Dunaif, A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr. Rev. 43, 927\u2013965 (2022).","journal-title":"Endocr. Rev."},{"key":"18867_CR63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni, N. E. H. et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell. Metab. 33, 513\u2013530e8 (2021).","journal-title":"Cell. Metab."},{"key":"18867_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41574-019-0314-3","volume":"16","author":"A Morris","year":"2020","unstructured":"Morris, A. Transgenerational effects of polycystic ovary syndrome identified. Nat. Rev. Endocrinol. 16, 67 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"18867_CR65","first-page":"17418","volume":"8","author":"S Zhang","year":"2015","unstructured":"Zhang, S. et al. Peroxisome proliferator-activated receptor gamma rs1801282 C\u2009>\u2009G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects. Int. J. Clin. Exp. Med. 8, 17418\u201317429 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"18867_CR66","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/cells11162569","volume":"11","author":"P Przybycie\u0144","year":"2022","unstructured":"Przybycie\u0144, P., G\u0105sior-Perczak, D., Placha, W., Cannabinoids, Ligands, P. P. A. R. & and The future in treatment of polycystic ovary syndrome women with obesity and reduced fertility. Cells 11, 2569 (2022).","journal-title":"Cells"},{"key":"18867_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41536-025-00414-1","volume":"10","author":"K Arkoudi","year":"2025","unstructured":"Arkoudi, K. et al. An NF-kB\/TNF-alpha signalling feedback loop acts to coordinate tissue regeneration and macrophage behaviour in zebrafish. Npj Regen Med. 10, 27 (2025).","journal-title":"Npj Regen Med."},{"key":"18867_CR68","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1096\/fj.202000052R","volume":"34","author":"CF Ruiz","year":"2020","unstructured":"Ruiz, C. F., Montal, E. D., Haley, J. A., Bott, A. J. & Haley, J. D. SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC. FASEB J. 34, 10574\u201310589 (2020).","journal-title":"FASEB J."},{"key":"18867_CR69","doi-asserted-by":"publisher","first-page":"952371","DOI":"10.3389\/fonc.2022.952371","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao, Q., Lin, X., Wang, G. & Targeting SREBP-1-Mediated lipogenesis as potential strategies for cancer. Front. Oncol. 12, 952371 (2022).","journal-title":"Front. Oncol."},{"key":"18867_CR70","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/jnci\/djn378","volume":"100","author":"S Yu","year":"2008","unstructured":"Yu, S. et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. JNCI: J. Natl. Cancer Inst. 100, 1630\u20131642 (2008).","journal-title":"JNCI: J. Natl. Cancer Inst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18867-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18867-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18867-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:07:14Z","timestamp":1758888434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18867-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18867"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18867-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was carefully reviewed and approved by the Ethics Committee of Affiliated Hospital of Nanjing University of Chinese Medicine (No.2021NL-019-03). All procedures performed in studies were in accordance with the ethical standards of Ethics Committee of Affiliated Hospital of Nanjing University of Chinese Medicine and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Ethical approval not required. Publicly accessible anonymized data from a secondary source repository was utilized. No direct interaction with individuals occurred.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"33252"}}